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Abstract
Background: Use of Carica papaya leaf extracts, reported to improve thrombocyte counts in dengue patients,
demands further analysis on the underlying mechanism of its thrombopoietic cytokines induction
Methods: In vitro cultures of peripheral blood leukocytes (PBL) and stem cells from human exfoliated deciduous
teeth (SHED) were treated with unripe papaya pulp juice (UPJ) to evaluate its potential to induce thrombopoietic
cytokines (IL-6 and SCF)
Results: In vitro scratch gap closure was significantly faster (p < .05) in SHED culture treated with UPJ. IL-6
concentration was significantly increased (p < .05) in SHED and PBL culture supernatant when treated with UPJ.
SCF synthesis in SHED culture was also significantly increased (p < .05) when treated with UPJ
Conclusion: In vitro upregulated synthesis of IL −6 and SCF both in PBL and SHED reveals the potential mechanism
of unripe papaya to induce thrombopoietic cytokines synthesis in cells of hematopoietic and mesenchymal origin.
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Background
Carica papaya leaves, seeds, roots and unripe pulp, have
been studied for their medicinal value such as, to treat
dengue fever [1, 2] and ulcer [3]; as antidiabetic and anti-
oxidant [4], antitumor and immunomodulatory [5], wound
healing [6], and antimicrobial agents [7, 8]. In relation to
treat dengue, C. papaya leaf extract was also found to im-
prove thrombocyte counts both in human [1] and murine
animal model [2, 9]. However, the mechanism of increased
thrombocyte production in response to the crude C. pa-
paya leaf extract is yet to be elucidated. One possible
mechanism might be attributed to the potential of papain
to induce thrombocytic cytokines such as IL-6. Notably,
unripe C. papaya is rich in proteases such as papain [10].
Purified papain was earlier reported to induce IL-6 se-
cretion in dose dependent manner in modified mixed
human lymphocyte culture [11]. Again, IL-6 stimulates
thrombocyte production by increasing thrombopoietin
(TPO) secretion in the liver [12]. Thus, it is expected that
papaya based extracts (PBE), rich in papain [10], might
also induce IL-6 and other thrombopoietic cytokines,
resulting in increased thrombocyte count. Therefore, we
have investigated in vitro thrombopoietic cytokines secre-
tion both by human peripheral blood leukocytes (PBL)
and stem cells from human exfoliated deciduous teeth
(SHED) in response to unripe C. papaya pulp juice.
Use of the PBL and SHED has allowed to evaluate
whether the potential of unripe C. papaya pulp juice to
enhance thrombopoietic cytokines is restricted to the cells
of hematopoietic origin such as PBL or, cells of other
origin such as SHED can also be induced for the same. As
one of the treatment strategies of thrombocytopenic
diseases, secretion of megakaryopoietic or thrombopoietic
affector molecules such as cytokines needs to be induced
not only by the cells of hematopoietic origin but also by
the cells of bone marrow, liver and kidney [12]. Therefore,
the current research adds evidence that papaya have the
potential to induce thrombopoietic cytokines synthesis by
cells of diverse tissue origin.
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The current study required samples from healthy human
donors. Therefore, this study was conducted according to
the guidelines laid down in the Declaration of Helsinki
and all procedures involving human subjects/patients were
approved by two different Ethics committee: human de-
ciduous dental pulp stem cells (SHED) were used with the
ethical approval granted by the Faculty of Dentistry
Medical Ethics Committee, University Malaya (DF
CO1107/0066(L)) and peripheral blood leukocytes (PBL)
were used with the ethical approval granted by the IIUM
Research Ethics Committee (ID: IREC 17).Verbal con-
sent was obtained from the PBL donors in the presence
of the certified individual designated for phlebotomy
and venipuncture. Written consent was obtained from
the SHED donors.
Unripe C. papaya pulp juice (UPJ) preparation
Unripe C. papaya was harvested from a farm in Kuantan,
Malaysia. The fruit was verified by Dr. Norazian Mohd
Hassan from the Kulliyyah of Pharmacy, IIUM (voucher
specimen no: PIIUM 0224). The fruit was washed with
distilled water, peeled, deseeded and the flesh was then
blended, and the resulting pulp was squeezed through a
mesh cloth to produce the unripe pulp juice (UPJ). The
UPJ was centrifuged at 2000 RPM at 4°C for 15 minutes
and supernatant was filtered using a sterile 0.22 μm syr-
inge filter (Millipore, USA). Filtration sterilization was ne-
cessary to use the juice for bacterial contamination free
cell culture. Other means of sterilization such as steam
heat sterilization was avoided to maintain the natural
composition of the juice. The sterilized UPJ was either
used immediately or stored at −80°C until further use.
Human deciduous dental pulp stem cells (SHED) culture
In brief, dental pulp was extirpated from caries free de-
ciduous teeth (n = 3) of healthy patients (aged 8–11 years)
undergoing extraction at the Department of Children
Dentistry and Orthodontics and Department of Oral and
Maxillofacial Surgery, Faculty of Dentistry University of
Malaya. Following extraction, the root surfaces were
cleaned with povidone-iodine (Sigma Aldrich, St Louis,
MO, USA) and the teeth were then placed into sterile so-
lution prior to sectioning. The teeth were sectioned at the
cemento-enamel junction using a diamond rotary disc and
the pulp were removed with an endodontic broach. The
pulp were then immediately placed into sterile microcen-
trifuge tubes containing transportation medium and trans-
ferred to the laboratory for stem cell isolation and in vitro
expansion as described earlier [13].
Dental pulp tissue was minced into small fragments
and digested using collagenase type I (Gibco, Grand Is-
land, NY, USA). SHEDs were cultured in Knockout™
DMEM (Gibco, USA) with 10% foetal bovine serum
(Gibco, USA), 1% Glutamax (Gibco, USA), 0.5% Penicillin-
Streptomycin antibiotics (Gibco, USA), and 0.5% antibiotic-
antimycotic (Gibco, USA). Cells were cultured and
expanded in T75 flasks under sterile conditions at 37°C and
5% CO2.
Peripheral blood leukocytes (PBL) collection and culture
Human peripheral blood samples were collected in ster-
ile tubes containing acid-citrate-dextrose (ACD), via
venipuncture at the median cubital vein of healthy do-
nors (n = 9). The blood components were separated by
density gradient centrifugation on Lymphoprep™ (Axis-
Shield, Norway). The layer of mononuclear cells was
subsequently removed and washed 3 times with PBS.
The resulting cell pellet was resuspended in culture
media, comprising of DMEM (Nacalai Tesque, Japan),
10% foetal bovine serum (JR Scientific, USA), and 1%
gentamicin-sulphate antibiotics (Nacalai Tesque, Japan).
Different concentrations of UPJ i.e., 2%, 5% and 10%
(v/v) were added to the media and cultured in 24-well
plates. PBL cultured without UPJ addition served as
the control group.
Scratch assay
Scratch assay was performed following methods previ-
ously described [14]. SHEDs were seeded into 6-well
plates and incubated at 37°C and 5% CO2. Once con-
fluenced, the UPJ was added to each well according to
the designated groups. A scratch was made in each well
using a 200 μl pipette tip. Average gap width was mea-
sured at three different points along the scratch, using
the ZEN 2011 Digital Imaging for Light Microscopy
computer program (Zeiss, Germany). The surface area
of the gap was computed using the ImageJ (National
Institute of Health, USA). The gap width and surface
area of the scratch was recorded at a 24 hour interval up
to 72 hours.
PrestoBlue® cell viability assay
Cell viability was evaluated using PrestoBlue® Cell Viability
Reagent (Invitrogen, USA). SHEDs were seeded in 96-well
plates and incubated 24 hours before addition of UPJ.
Every 24 hours over three days, PrestoBlue® reagent was
added to each well and the plates were further incubated
for 2 hours at 37°C. Absorbance was measured at 570 nm
with reference wavelength set at 600 nm. PrestoBlue® ab-
sorbance was used to estimate the cell viability. The
absorbance values were converted to the percentage re-
duction of PrestoBlue® reagent using the molar extinction
coefficients of the oxidized and reduced forms of the re-
agent. The greater the percent reduction of PrestoBlue®
reagent, the higher is the cell viability.
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Total protein analysis
Concentration of total protein in PBL culture super-
natant was measured using the Quick Start™ Bradford
Protein Assay (Bio-Rad, USA). The culture supernatant
samples and Bradford reagent were added to a 1 mL cu-
vette and mixed thoroughly. After allowing the mixture
to settle for five minutes, absorbance was measured at
595 nm. The concentration of protein in each sample
was estimated from a standard curve constructed using
prepared standards from the kit.
IL-6 and IL-3 ELISA
Concentration of IL-6 and IL-3 in PBL culture super-
natant was measured using Quantikine® ELISA Kit (R&D
Systems, USA). PBL culture supernatant was added to
96-well plates pre-coated with monoclonal antibodies
specific for the target cytokine and incubated for two
hours at room temperature. The wells were then washed
followed by the addition of HRP-conjugated secondary
antibodies and incubated for two hours at room
temperature. The wells were again washed before adding
the substrate solution. Finally, the stop solution was added
after 20 minutes and absorbance was measured at 450 nm
with wavelength correction set to 540 nm. Concentration
of cytokines in samples was estimated from a standard
curve using standards prepared from serial dilution.
ProcartaPlex™ multiplex immunoassay
SHED culture supernatant was collected from the cultures
used in the scratch assay after 24 hours and stored in −80°
C until the assay was performed. A customised Procarta-
Plex™ Multiplex Immunoassay (Affymetrix, USA) was used
for quantitative measurements of six cytokines; interleukin-
6 (IL-6), interleukin-3 (IL-3), thrombopoietin (TPO),
granulocyte-macrophage colony-stimulating factor (GM-
CSF), granulocyte colony-stimulating factor (G-CSF) and
stem cell factor (SCF).
Statistical analysis
Results are reported as mean ± standard error of the
mean. The Wilcoxon Signed Rank test was performed to
determine if there was any significant difference between
the three UPJ groups and control group. The α value
was set at 0.05.
Results
Gap closure in SHED scratch assay is enhanced by UPJ
The width and surface area of the gap was obtained
from the scratch assay to determine the effect of UPJ on
SHED proliferation. Both the width (Fig. 1a) and surface
area (Fig. 1b) of the gap was significantly reduced with
the addition of 10% (v/v) UPJ compared to the control
(p = .008). At 72 hours, cell viability in the 10% (v/v) UPJ
group was slightly higher compared to control and other
treatment groups (Fig. 1g), however the difference was
not statistically significant (p = .173).
Secretion of IL-6 in SHED culture is significantly enhanced
by UPJ
Of the six cytokines measured, only IL-6, IL-3, TPO and
SCF were detectable in the assay (Fig. 2), while G-CSF
and GM-CSF were below the assay’s level of detection.
IL-6 was significantly increased (p = .008) with the
addition of 5% and 10% UPJ (Fig. 2a). increase of SCF
secretion compared to the control after addition of 5%
and 10% UPJ was statistically significant (p = .046 and
p = .018 respectively) (Fig. 2d). Concentration of IL-3 de-
clined with the addition of higher concentrations of UPJ
(Fig. 2b) while concentration of TPO remained relatively
constant across all groups (Fig. 2c).
Enhanced IL-6 secretion in PBL culture with 2% UPJ
Concentration of IL-6 and IL-3 were measured in PBL
culture supernatants. IL-6 concentration was signifi-
cantly increased with the addition of 2% UPJ (p = .008).
However, IL-6 concentration decreased with the addition
of higher concentration of UPJ (Fig. 3b). On the other
hand, total protein concentration was significantly de-
creased with the addition of 10% UPJ (p = .008) (Fig. 3a).
IL-3 was not detectable by the assay.
Discussion
Papaya leaves extract, rich in papain, was shown to im-
prove thrombocyte (platelet) count in dengue patients [2]
as well as in murine animal model [9]. Together, these ob-
servations compel further research on the underlying
mechanism of thrombopoietic potential of PBE. The most
likely mechanism could be linked with the upregulated
thrombopoietic cytokines such as IL-6, SCF, IL-3 and
TPO in response to PBEs, of which a major bioactive con-
stituent is papain [10]. Earlier, purified papain was shown
to induce IL-6 synthesis in a dose dependent manner in
modified mixed lymphocyte culture [11]. In relation to the
use of papaya leaf extract to treat dengue, it is important
to ascertain if the PBE, similar to papain, can also induce
thrombopoietic cytokines.
Therefore, the primary objective of this study is to dem-
onstrate potential of PBE to induce thrombopoietic cyto-
kines by the cells of the hematopoieteic origin. It is also
important to evaluate whether the thrombopoietic poten-
tial of PBE is restricted to the cells of hematopoietic origin,
since different thrombopoietic cytokines are synthesized
by cells of different tissue origin such as IL-6 by cells of
the circulatory system and TPO by the kidney [12]. There-
fore, in the current study we have investigated in vitro in-
duction of thrombopoietic cytokines by UPJ both in
human PBLs of hematopoitic origin and in SHED, origin
of which is entirely different from the hematopoietic cells
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Fig. 1 Unripe papaya pulp juice promotes gap closure in vitro SHED scratch culture. Addition of 10% UPJ significantly (p = .008) reduced scratch gap
width (a) and gap area (b) compared with control groups. Addition of 2% and 5% UPJ did not show any significant difference. Representative
photomicrographs of scratch assay of control and 10% UPJ groups at 0 hour (c and e respectively) and 24 hour (d and f respectively). Dotted lines
(c and e) show initial scratch. In vitro addition of 2%, 5% and 10% UPJ did not significantly affect SHEDs’ viability (g). *Significantly higher than control
group (p = .008); n= 9; [scale bar (C-F): 50 μm]
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[15, 16]. SHED has been an convenient source since it
does not involve invasive route of collection. It is hoped
that the current study would encourage furhter research
using other potential organs involved in hematopoiesis
such as bone marrow, kidney and liver.
Notably, SHED has been reproted to share characteris-
tics of the mesenchymal stem cells (MSC) [15, 17, 18]
such as plastic adherence, osteogenic and chondrogenic
differentiation potential (Additional file1: Figure S1).
Furthermore, MSCs in bone marrow play important
role in regulating haematopoiesis [19, 20]. Therefore,
increased secretion of thrombopoietic cytokines by
SHED in response to UPJ would demonstrate the poten-
tial of papaya to induce thrombopoiesis involving
hematopoietic as well as other tissues such as bonemar-
row, kindney and liver [12].
Fig. 2 Unripe papaya pulp juice enhances in vitro IL-6 synthesis in SHED in dose dependent manner. A significant increase in IL-6 (a) synthesis
was found in the 10% UPJ group compared to the control, 2% UPJ and 5% UPJ groups (p = .008), while the 5% UPJ group produced significantly
higher IL-6 compared to control and the 2% UPJ group (p = .008). Synthesis of IL-3 (b), TPO (c) and SCF (d) was not significantly different between
groups. *Significantly higher compared to control and 2% UPJ group (p = .008); #Significantly higher than 5% UPJ group (p = .008); n = 9
Fig. 3 Unripe papaya pulp jucie enhances in vitro IL-6 secretion by human PBL. A significantly increased amount (p = .008) of IL-6 was found in
supernatant of the in vitro PBL culture added with 2% UPJ compared to control and the 10% UPJ groups (b). Total protein content in the PBL
culture supernatant added with 10% UPJ was significantly lower (p = .008) compared to control group (a). *Significantly higher compared to
control group (p = .008); #Significantly higher compared to 10% UPJ group (p = .008); n = 9
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Papain is one of the major cystein endopeptidases,
which also include chymopapain, caricain and glycyl endo-
peptidase [10]. These four endopeptidases are found in
latex, which can be found in differing amounts in the fruit,
leaves and roots. With higher amounts of latex, and thus
papain to be found in the unripe fruit, UPJ is expected to
exert same therapeutic effects as papaya leaf.
We have observed that in vitro viability of SHED is not
affected by the addition of until 10% (v/v) UPJ (Fig. 1g).
Additionally, UPJ helped proliferation of SHED in a dose
dependent manner and the proliferation was significantly
higher compared to the control culture when treated with
10% (v/v) UPJ (Fig. 1A-1F). This increased rate of prolifer-
ation of SHED is significant since it has been shown that
Fig. 4 Proposed mechanism of IL-6 induced thrombocyte production. Addition of UPJ may enhance IL-6 secretion by both haematopoietic stem cells
(HSC) and mesenchymal stem cells (MSC) such as SHED. IL-6 can then directly enhance HSC proliferation, maturation and differentiation, or act on the
liver to stimulate higher production of TPO, the chief cytokine involved in megakaryopoiesis and thrombopoiesis. Increased synthesis of SCF by MSC
may also act on TPO to further stimulate megakaryopoiesis and thrombopoiesis. [CMP: common myeloid progenitor; MK: megakaryocyte.]
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the number of HSCs in bone marrow is directly propor-
tional to that of mesenchymal stem cells [19]. Thus, an in-
creased rate of SHED proliferation should also lead to an
increased rate of HSC proliferation, which could boost
thrombocyte production. One possible mechanism for the
increased proliferation could be related to papain in the
UPJ which was earlier reported to shorten G0 phase of the
cell cycle or recruit more dormant stem cells into the cell
cycle [21].
We have also observed an increased IL-6 synthesis by
the in vitro SHEDs when treated with increasing con-
centration of UPJ (Fig. 2a). And IL-6 synthesis was sig-
nificantly higher in 10% (v/v) UPJ treated culture
compared to the 2%, 5% (v/v) UPJ treated and control
cultures. Under normal physiological conditions, IL-6 is
synthesised in various tissues and cell types including
macrophages, lymphocytes, fibroblasts, keratinocytes
and osteoblasts. As a pleiotropic cytokine, IL-6 acts on
hepatocytes in the liver, stimulating the increased ex-
pression of the otherwise constitutively produced throm-
bopoietin (TPO), one of the major cytokines to induce
megakaryopoiesis or thrombopoiesis resulting in in-
creased thrombocyte counts [12, 22].
Increased IL-6 expression could also lead to an in-
creased rate of thrombocyte production by stimulating
proliferation of multipotential haematopoietic progeni-
tors [22, 23]. As a result of the increase in haematopoi-
etic progenitor cell proliferation, mature megakaryocytes
will increase in number, leading to a rise in thrombocyte
counts. The observed enhanced cell proliferation (Fig. 1)
could also be aided by an increased production of SCF
(Fig. 2d). This notion is consistent with earlier reports that
SCF acts in synergy with other cytokines, such as TPO to
increase the proliferation of immature progenitor cells
[24], this too helps in the thrombocyte production.
Since TPO is the major cytokine involved in megakar-
yopoiesis and thrombopoiesis, it is possible that papaya
extract/juice enhances thrombocyte production by first
increasing IL-6 expression in stem cells and leukocytes,
as shown in this study, which in turn enhances the pro-
duction of TPO in the liver, leading to an increased rate
of thrombocyte production (Fig. 4).
Unlike the dose dependent induction of IL-6 synthesis
by SHEDs culture (Fig. 2a), addition of 2% (v/v) UPJ re-
sulted in highest amount of IL-6 secretion in PBL cul-
ture supernatant compared to the addition of 10% (v/v)
UPJ (Fig. 3b). Earlier it was established that induction of
IL-6 synthesis may involve different pathways. Such as,
IL-6 synthesis in human fibroblasts can be induced ei-
ther by triggering protein kinase C [25] or by increased
intracellular cyclic AMP [26]. Furthermore, induction of
IL-6 synthesis can be both cell and inducer specific. For
example, endotoxin is a stronger inducer in cultured
monocytes than in terminally differentiated macrophages.
Again, IL-1 was able to stimulate IL-6 synthesis in mono-
cytes, but not in macrophages [27]. IL-6 synthesis was also
found to be inhibited differently in different tissue, such as
glucocorticosteroids prevent IL-6 gene transcription in
human peripheral blood mononuclear cells [28]. In re-
lation to PBEs, its major constituents papain and chy-
mopapain were reported to mediate inflammation by
stimulating the synthesis of prostaglandins [29]. There-
fore, it is not unlikely that higher concentration of UPJ
i.e., 10% (v/v) might have stronger inhibitory effect on
IL-6 synthesis in PBL through stimulation of prosta-
glandins. At the same time it can be speculated, since
similar effect is not observed, inhibition of IL-6 synthe-
sis in SHED may follow a different pathway. Other pos-
sible clue could be the differences in number of
actively proliferating cells. Compared to abundant pro-
liferating cells in SHED culture, PBL culture is mainly
composed of terminally differentiated nonproliferating
lymphocytes, monocytes, macrophages and other sub-
population of leukocytes.
Conclusion
While different medicinal plants were shown to have anti
dengue virus activity [30], PBE being a strong stimulant of
IL-6 and SCF, might help to improve thrombocytopenic
conditions of the infected patients. Nonetheless, the use of
PBE for dengue treatments needs more attention since IL-6
synthesis in monocyte culture was reported to be age
dependent [31] and dengue virus sero-type specific [32].
Finally, although papain was proven to be the potent IL-6
inducer [11], it is important to link other bioactive compo-
nent(s) of PBE for its thrombopoietic potential.
Additional file
Additional file 1: Figure S1. Characterizationof the dental pulp derived
SHED. Plastic adherence of SHED (A-C). Dental pulp tissue primary culture
on day 7 (A); after 72 hours of incuabation, passage 3 (B); after 144 hours
of incubation, passage 5 (C). Trilineage differentiation of SHED (D-F).
SHEDs were cultured in chondrogenic and adipogenic differentiation
medium for 14 days, and in osteogenic differentiation medium for 21
days. (D) After 14 days chondrogenic differentiation, checked by staining
the cells with 'Safranin-O’. (E) After 14 days adipogenic differentiation,
checked by staining with ‘Oil red O’. (F) after 21 days osteogenic
differentiation, checked by staining with ‘Alizarin Red’. Photomicrographs
were taken using inverted microscope (Zeiss, Germany).
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